Identification of two main urinary metabolites of [14C]omeprazole in humans.
The excretion and metabolism of [14C]omeprazole given orally as a suspension was studied in 10 healthy male subjects. An average of 79% of the dose was recovered in the urine in 96 hr, with most of the radioactivity (76% of dose) being eliminated in the first 24 hr. Pooled urine (0-2 hr) from five subjects, containing about 47% of the dose, was analyzed by reverse phase gradient elution LC with radioisotope detection. Omeprazole was completely metabolized to at least six metabolites. The two major metabolites were extensively purified by LC and their structures were determined by MS with derivatization and use of stable isotopes, 1H NMR, and comparison with synthetic references. They were formed by hydroxylation of a methyl group in the pyridine ring, followed by further oxidation of the alcohol to the corresponding carboxylic acid. Both metabolites retained the sulfoxide group of omeprazole, rendering them as unstable as the parent compound at pH less than 7. They accounted for approximately 28% (hydroxyomeprazole) and 23% (omeprazole acid) of the amount excreted in the 0-2-hr collection interval. Based on in vitro studies with the synthetic metabolites in isolated gastric glands, it is unlikely that M1 and M2 will contribute to the pharmacological effect of omeprazole in humans.
Renberg
L
L
Department of Pharmacokinetics and Drug Metabolism, AB Hässle, Mölndal, Sweden.
Simonsson
R
R
Hoffmann
K J
KJ
D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D002250:Carbon Radioisotopes; D002853:Chromatography, Liquid; D006801:Humans; D009682:Magnetic Resonance Spectroscopy; D013058:Mass Spectrometry; D009853:Omeprazole / Q000031:analogs & derivatives* / Q000378:metabolism* / Q000652:urine
D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D002250:Carbon Radioisotopes; C059851:omeprazole acid; C049963:5-hydroxymethylomeprazole; D009853:Omeprazole